January 28, 2016

Terumo and Quirem Medical Expand Strategic Alliance

Terumo Corporation and Quirem Medical Expand Strategic Alliance, including a global distribution agreement and a future buy-out option

Terumo Corporation and Quirem Medical B.V., a commercial stage Dutch medical technology company that focuses on radioembolization, today announced that Terumo will become the exclusive global distributor for the radioembolization solutions developed by Quirem Medical and has furthermore obtained a buy-out option.

Read the official Terumo news statement here

Other News

February 13, 2019

The first QuiremScout™ cases successfully performed

The first QuiremScout™ cases have been successfully performed by clinical teams in Dresden and Pisa last week. We congratulate the clinical teams, and everyone involved! QuiremScout™ is the fi...

January 7, 2019

QuiremScout™ receives CE mark and is the first and only CE marked product that is indicated for SIRT work up.

Terumo Europe today announced that QuiremScout™ has received CE mark, making it available as the first and only CE marked product indicated for SIRT work up, for clinical centers throughout Europe. ...

December 21, 2018

Radboudumc performs their first QuiremSpheres® treatment

We are pleased to announce that the Radboudumc in Nijmegen has treated its first patient with QuiremSpheres®. This milestone has been made possible by an interdisciplinary team, consisting of Dr. Mar...